Current Drug Safety

Managing Safety Signals in Large Endpoint Trials
pp. 86-90(5)
Author: Alemayehu, Demissie

Immune Monitoring to Predict the Development of Infections After Immunosuppression for Solid Organ Transplantation and Autoimmune Diseases
pp. 91-99(9)
Authors: Carbone, Javier; Lanio, Nallibe; Gallego, Antonio; Sarmiento, Elizabeth

Advances in Machine Learning Prediction of Toxicological Properties and Adverse Drug Reactions of Pharmaceutical Agents
pp. 100-114(15)
Authors: Ma, Xiao H.; Wang, Rong; Xue, Yin; Li, Ze R.o.n.g.; Yang, Sheng Y.o.n.g.; Wei, Yu Q.u.a.n.; Chen, Yu Z.o.n.g.

Side Effects of Clozapine and Some Other Psychoactive Drugs
pp. 115-122(8)
Author: Flanagan, Robert J.

The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database
pp. 123-131(9)
Authors: McAfee, Andrew T.; Holdridge, Karen C.; Johannes, Catherine B.; Hornbuckle, Kenneth; Walker, Alexander M.

Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data
pp. 132-142(11)
Authors: Wernicke, Joachim; Pangallo, Beth; Wang, Fujun; Murray, Isabelle; Henck, Judith W.; Knadler, Mary P.; D'Souza, Deborah N.; Uetrecht, Jack P.

Hepatic Effects of Duloxetine-II: Spontaneous Reports and Epidemiology of Hepatic Events
pp. 143-153(11)
Authors: Wernicke, Joachim; Acharya, Nayan; Strombom, Indiana; Gahimer, James L.; D'Souza, Deborah N.; DiPietro, Natalie; Uetrecht, Jack P.

Hepatic Effects of Duloxetine-III: Analysis of Hepatic Events Using External Data Sources
pp. 154-162(9)
Authors: Strombom, Indiana; Wernicke, Joachim F.; Seeger, John; D'Souza, Deborah N.; Acharya, Nayan

Laboratory Monitoring of Hematological and Hepatic Parameters in Ambulatory Patients Receiving Alpha-Methyldopa in a Nigerian Tertiary Care Setting
pp. 163-166(4)
Authors: Yusuff, Kazeem B.; Ajayi, Adeola; Joseph, Yunana B.o.n.a.t.s.o.n.